Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Director Declaration

17 Mar 2017 15:17

RNS Number : 8560Z
Dechra Pharmaceuticals PLC
17 March 2017
 

 

 

 

17 March 2017

 

Dechra® Pharmaceuticals PLC

("Dechra" or "the Company")

Director's Declaration

 

 

 

In accordance with Listing Rule 9.6.14(2) Dechra announces that Ishbel Macpherson, Non-Executive Director of Dechra, is to be appointed as a

Non-Executive Director of Fidessa group plc with effect from 1 May 2017.

 

 

 

For further information:

 

Suzana Cross, Company Secretary and General Counsel

Telephone number: 01606 814730

 

 

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business. Its expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com

 

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDNBUGDXUBBBGRR

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.